Lazard Asset Management LLC Pacira Bio Sciences, Inc. Transaction History
Lazard Asset Management LLC
- $58.2 Billion
- Q1 2025
A detailed history of Lazard Asset Management LLC transactions in Pacira Bio Sciences, Inc. stock. As of the latest transaction made, Lazard Asset Management LLC holds 151,028 shares of PCRX stock, worth $3.66 Million. This represents 0.01% of its overall portfolio holdings.
Number of Shares
151,028
Previous 43,491
247.26%
Holding current value
$3.66 Million
Previous $819,000
358.24%
% of portfolio
0.01%
Previous 0.0%
Shares
12 transactions
Others Institutions Holding PCRX
# of Institutions
254Shares Held
51.1MCall Options Held
157KPut Options Held
139K-
Black Rock Inc. New York, NY8.01MShares$194 Million0.01% of portfolio
-
Vanguard Group Inc Valley Forge, PA5.24MShares$127 Million0.0% of portfolio
-
D. E. Shaw & Co., Inc. New York, NY2.26MShares$54.9 Million0.06% of portfolio
-
Jim Simons Renaissance Technologies LLC | New York, Ny2.24MShares$54.3 Million0.09% of portfolio
-
Dimensional Fund Advisors LP Austin, TX2.05MShares$49.7 Million0.01% of portfolio
About Pacira BioSciences, Inc.
- Ticker PCRX
- Exchange NASDAQ
- Sector Healthcare
- Industry Drug Manufacturers—Specialty & Generic
- Shares Outstandng 45,824,200
- Market Cap $1.11B
- Description
- Pacira BioSciences, Inc. provides non-opioid pain management and regenerative health solutions for healthcare practitioners and their patients in the United States. The company offers EXPAREL, a bupivacaine liposome injectable suspension; ZILRETTA, a triamcinolone acetonide extended-release injectable suspension; and iovera system, a non-opioid ...